30
Participants
Start Date
April 30, 2016
Primary Completion Date
June 15, 2018
Study Completion Date
June 15, 2018
The Lutronic electronic carbon dioxide (eCO2) Plus laser system
CO2 ablative laser plus intralesional triamcinolone acetonide A topical EMLA cream or tetracaine 7%/lidocaine 23% will be applied to the both treatment sites and after sufficient anesthesia is attained, one keloid will be treated with the fractional CO2 laser using standard protocol as practiced in our clinics followed by intralesional triamcinolone acetonide. One lesion would be treated with fractional CO2 ablative laser followed with intralesional triamcinolone acetonide at 4 weeks intervals
Intralesional Triamcinolone Acetonide
Johns Hopkins School of Medicine, Department of Dermatology, Baltimore
Johns Hopkins University
OTHER